February 2015

Safety Related Changes

CellCept (mycophenolate mofetil) is now also contraindicated during pregnancy due to its mutagenic and teratogenic potential; in women of childbearing potential not using highly effective contraceptive methods; and in women who are breastfeeding.

Patients should be advised that alcohol intake may increase the risk of experiencing neuropsychiatric events during treatment with Champix (varenicline (as tartrate)).

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia┬áPty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au